Get started
Author

Maciej J. Pelak

Observed names: M J Pelak, M Pelak, M. J. Pelak, M. Pelak, Maciej J Pelak, Maciej Pelak, MaciejJ Pelak
Institution: MedAustron
Observed institutions: Medical University of Lublin, University of Salzburg, Paracelsus Medical University, Paul Scherrer Institute, Universitätskliniken Salzburg, Salzburger Landeskliniken, The Maria Sklodowska-Curie National Research Institute of Oncology, MedAustron
ORCID: 0000-0001-9584-2996
Observed ORCID: 0000-0001-9584-2996
OpenAlex ID: A5073711962
Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer
2015 · Kinga Grabinska, Maciej Pelak, et al. · World Journal of Gastroenterology · 33
PDF
Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: Translations between LEM and MKM RBE models and preliminary clinical results
2022 · Sarah Grosshagauer, Piero Fossati, et al. · Radiotherapy and Oncology · 26
Clinical outcomes of head and neck adenoid cystic carcinoma patients treated with pencil beam-scanning proton therapy
2020 · Maciej J. Pelak, Marc Walser, et al. · Oral Oncology · 25
PDF
The prognostic significance of indoleamine-2,3-dioxygenase and the receptors for transforming growth factor β and interferon γ in metastatic lymph nodes in malignant melanoma
2016 · Maciej J. Pelak, Mirosław Śnietura, et al. · Polish Journal of Pathology · 16
PDF
Prospective Analysis of Radiation-Induced Contrast Enhancement and Health-Related Quality of Life After Proton Therapy for Central Nervous System and Skull Base Tumors
2024 · Carola Lütgendorf-Caucig, Maciej Pelak, et al. · International Journal of Radiation Oncology*Biology*Physics · 13
PDF
The Value of SSTR2 Receptor-Targeted PET/CT in Proton Irradiation of Grade I Meningioma
2021 · Maciej J. Pelak, Birgit Flechl, et al. · Cancers · 13
PDF
A Review of Particle Therapy for Skull Base Tumors: Modern Considerations and Future Directions
2021 · Eugen B. Hug, Maciej Pelak, et al. · International Journal of Particle Therapy · 12
Proton or Carbon Ion Therapy for Skull Base Chordoma: Rationale and First Analysis of a Mono-Institutional Experience
2023 · Slavisa Tubin, Piero Fossati, et al. · Cancers · 10
PDF
The Prognostic value of pretreatment gallium-68 DOTATATE positron emission tomography/computed tomography in irradiated non-benign meningioma
2019 · MaciejJ Pelak, Andrea d'Amico · Indian Journal of Nuclear Medicine · 7
The trends and significance of SSTR PET/CT added to MRI in follow-up imaging of low-grade meningioma treated with fractionated proton therapy
2022 · Carola Lütgendorf-Caucig, Maciej Pelak, et al. · Strahlentherapie und Onkologie · 4
Patient-Reported Outcomes, Neurocognitive Functioning, and Oncologic Results of Pencil Beam Scanning Proton Beam Therapy for CNS WHO G2 and G3 IDH1-Mutant Diffuse Adult Glioma: A Single Institution Experience
2025 · Maciej J. Pelak, Allan Hummer, et al. · International Journal of Radiation Oncology*Biology*Physics · 3
PDF
The application of 18F-FDG-PET/CT in gastric cancerstaging and factors affecting its sensitivity.
2024 · Kinga Dębiec, Jerzy Wydmański, et al. · PubMed · 3
The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study
2024 · Carola Lütgendorf-Caucig, Patricia Wieland, et al. · Cancers · 3
The presence and clinical implications of α-2,6-galactose-linked sialic acids in non-small-cell lung cancer brain metastases — preliminary study
2014 · Maciej J. Pelak, Bozena Jarosz, et al. · Folia Histochemica et Cytobiologica · 3
PDF
OS6.5 The prognostic usability of Ga68-DOTA-TATE PET-CT in irradiated meningioma
2016 · M. J. Pelak, A. d’Amico, et al. · Neuro-Oncology · 2
PDF
Carbon-Ion Radiotherapy for Head and Neck Mucosal Melanoma: Preliminary Clinical Outcomes and the MedAustron Approach for Reporting RBE-Weighted Dose With 2 Models
2025 · Ankita Nachankar, Maciej Pelak, et al. · International Journal of Particle Therapy · 1
P18.09.a Proton Therapy for Patients With Meningioma - What About Financial Toxicity and Occupational Status?
2023 · B Flechl, M Achtaewa, et al. · Neuro-Oncology · 1
PDF
Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
2022 · Maciej J. Pelak, Birgit Flechl, et al. · Frontiers in Oncology · 1
PET/CT Biological Imaging of Irradiation-Treated Tumors: Which Studies may Lead to an Improvement in Curability?
2016 · Maciej Pelak · Cancer clinical trials · 1
Evident clinical response to erlotinib as third-line treatment in EGFR FISH (+) male smoker patient with adenocarcinoma of lung
2009 · Paweł Krawczyk, W Remiszewski, et al. · American Journal of Case Reports · 1
Clinical Outcomes of Particle Therapy for Sinonasal Adenocarcinoma
2026 · Maciej Pelak, Eugen Hug, et al. · International Journal of Particle Therapy
PDF
Financial and occupational recovery after proton therapy for meningioma: Results from the REGI-MA-002015 study
2026 · Birgit Flechl, Milana Achtaewa, et al. · International Journal of Particle Therapy
P09.03.b Oncologic and Patient-reported Outcomes of Pencil-beam-scanning Proton Beam Therapy for Cns Who G2 and G3 Idh1-mutant Glioma: a Single Institution Experience
2025 · M J Pelak, A Hummer, et al. · Neuro-Oncology
PDF
2789: First clinical experience of fractionated proton radiotherapy of schwannomas of the cranial nerves
2024 · Petra Mozes, Carola Lütgendorf-Caucig, et al. · Radiotherapy and Oncology
2689: First clinical results after proton therapy in patients with aggressive pituitary macroadenomas
2024 · Birgit Flechl, Eugen Hug, et al. · Radiotherapy and Oncology
Works count: 42
Citation count: 178
H-index: 8
I10-index: 8
Year
Topic
Type